Genezen breaks ground on cGMP lentiviral vector production facility
Genezen Laboratories, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production and analytical testing services, has broken ground on a new multiphase master plan for a...
Genezen Strengthens Leadership with New Board Appointments
Following major growth, Genezen Laboratories Inc, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has announced the appointment of three board members: Iain Baird, Diana Caldwell and Tedd Green. The expansion of the team...
Genezen Laboratories Receives Growth Equity Investment from Ampersand Capital Partners
Genezen Laboratories, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production, and analytical testing services, today announced a majority investment from Ampersand Capital...
IBJ Names Genezen “Fastest Growing” in 2020
Indiana Business Journal has named Genezen Laboratories the fastest growing company in central Indiana! Revenue growth FY 2017 to 2019: 424% 2019 revenue: $15.1 million Light bulb moment: Bill Vincent had been working for the Indianapolis company Rimedion, which was...
Recent Comments